# To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Controlled-Release Tablets 600 mg in Comparison to the Reference Standard Ibuprofen Tablets in Normal Healthy Volunteers

> **NCT03418805** · PHASE1 · TERMINATED · sponsor: **Overseas Pharmaceuticals, Ltd.** · enrollment: 31 (actual)

## Conditions studied

- Pain Control

## Interventions

- **DRUG:** Advil Ibuprofen table 200 mg
- **DRUG:** Motrin IB Ibuprofen Tablets 200 mg
- **DRUG:** Ibuprofen CR Tablets 600 mg

## Key facts

- **NCT ID:** NCT03418805
- **Lead sponsor:** Overseas Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-11
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Sponsor's consideration of product development strategies
- **Last updated:** 2022-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03418805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03418805, "To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Controlled-Release Tablets 600 mg in Comparison to the Reference Standard Ibuprofen Tablets in Normal Healthy Volunteers". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03418805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*